Related references
Note: Only part of the references are listed.IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in ovarian cancer cells
Minghua Zou et al.
CELLULAR ONCOLOGY (2016)
A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells
Vijaya Narasihma Reddy Gajulapalli et al.
BIOCHEMICAL JOURNAL (2016)
HPIP promotes non-small cell lung cancer cell proliferation, migration and invasion through regulation of the Sonic hedgehog signaling pathway
Jia Pan et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Upregulation of ABCG2 via the PI3K-Akt pathway contributes to acidic microenvironment-induced cisplatin resistance in A549 and LTEP-a-2 lung cancer cells
Chun Fang Hu et al.
ONCOLOGY REPORTS (2016)
HPIP Silencing Prevents Epithelial-Mesenchymal Transition Induced by TGF-β1 in Human Ovarian Cancer Cells
Guo-ying Zhang et al.
ONCOLOGY RESEARCH (2016)
Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells
Justyna Mikula-Pietrasik et al.
CELLULAR ONCOLOGY (2016)
Reversal of cisplatin resistance by inhibiting PI3K/Akt signal pathway in human lung cancer cells
Y. Zhang et al.
NEOPLASMA (2016)
HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway
Shun-chang Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion
Yingying Feng et al.
CANCER SCIENCE (2015)
Metformin and epithelial ovarian cancer therapeutics
Seema Patel et al.
CELLULAR ONCOLOGY (2015)
Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis
Seiji Okada et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2015)
Hematopoietic PBX-interacting protein (HPIP) is over expressed in breast infiltrative ductal carcinoma and regulates cell adhesion and migration through modulation of focal adhesion dynamics
S. Bugide et al.
ONCOGENE (2015)
HPIP is upregulated in colorectal cancer and regulates colorectal cancer cell proliferation, apoptosis and invasion
Yingying Feng et al.
Scientific Reports (2015)
MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradation
K. Shostak et al.
CELL DEATH AND DIFFERENTIATION (2014)
Follicle-Stimulating Hormone Induced Epithelial-Mesenchymal Transition of Epithelial Ovarian Cancer Cells Through Follicle-Stimulating Hormone Receptor PI3K/Akt-Snail Signaling Pathway
Yongbin Yang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Pre-B-cell leukemia homeobox interacting protein 1 is overexpressed in astrocytoma and promotes tumor cell growth and migration
Dannis G. van Vuurden et al.
NEURO-ONCOLOGY (2014)
Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors
Karen E. Sheppard et al.
EUROPEAN JOURNAL OF CANCER (2013)
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
Roel G. W. Verhaak et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis
Xiaojie Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
KDM1 is a novel therapeutic target for the treatment of gliomas
Gangadhara R. Sareddy et al.
ONCOTARGET (2013)
Platinum-sensitive recurrence in ovarian cancer: the role of tumor microenvironment
Jeremy Chien et al.
FRONTIERS IN ONCOLOGY (2013)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Genomic Complexity and AKT Dependence in Serous Ovarian Cancer
Aphrothiti J. Hanrahan et al.
CANCER DISCOVERY (2012)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
Epithelial-mesenchymal transition in ovarian cancer
Daniele Vergara et al.
CANCER LETTERS (2010)
Ovarian Cancer
Kathleen R. Cho et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay
Veronika Auner et al.
BMC CANCER (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Beyond chemotherapy: targeted therapies in ovarian cancer
Timothy A. Yap et al.
NATURE REVIEWS CANCER (2009)
A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer
Tomas Bonome et al.
CANCER RESEARCH (2008)
Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis
Yoshiko Kuwabara et al.
CANCER SCIENCE (2008)
Epithelial-mesenchymal transition in ovarian cancer progression:: A crucial role for the endothelin axis
Anna Bagnato et al.
CELLS TISSUES ORGANS (2007)
Ovarian cancer
Nicoletta Colombo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
An inherent role of microtubule network in the action of nuclear receptor
Bramanandam Manavathi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Ovarian cancer metastasis: Integrating insights from disparate model organisms
H Naora et al.
NATURE REVIEWS CANCER (2005)
Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line
S Lee et al.
GYNECOLOGIC ONCOLOGY (2005)
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth
DA Altomare et al.
ONCOGENE (2004)
PI3K-Akt pathway: Its functions and alterations in human cancer
M Osaki et al.
APOPTOSIS (2004)
Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition
BHP Zhou et al.
NATURE CELL BIOLOGY (2004)
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
G Singer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells
M Sun et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas
K Kurose et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Long-term results and prognostic factors in patients with epithelial ovarian cancer
JL Brun et al.
GYNECOLOGIC ONCOLOGY (2000)
Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer
ZQ Yuan et al.
ONCOGENE (2000)
The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression
A Cano et al.
NATURE CELL BIOLOGY (2000)
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
E Batlle et al.
NATURE CELL BIOLOGY (2000)
Share Paper
